)
Byhealth (300146) investor relations material
Byhealth Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
9M 2026 revenue rose 7.78% YoY to ¥5.298bn; net income attributable to shareholders fell 10.42% to ¥812.7m, while adjusted net income fell 11.93% to ¥728.3m.
Strategy focused on growth, digital infrastructure for offline channels, multiple online growth models and accelerating high-potential businesses.
Financial highlights
Q3 revenue was ¥1.626bn, up 17.60% YoY; attributable net income was ¥209.6m, up 22.73%, and adjusted net income was ¥171.7m, up 28.65%.
9M operating profit was ¥1.031bn versus ¥1.135bn a year earlier; net income was ¥826.8m versus ¥944.3m.
9M R&D expense increased 44.79% to ¥80.1m; financial expenses were ¥8.6m versus income of ¥14.1m a year earlier, reflecting lower deposit interest income and higher FX losses.
Segment performance
9M brand revenue: core brand ¥2.789bn, up 4.24%; JIANLIGUO ¥579m, up 0.88%; lifespace ¥1.073bn, up 13.52%.
9M offline revenue was ¥2.414bn, down 2.16%; online revenue was ¥2.860bn, up 19.79%.
- Revenue up 3.94% but net profit down 18.11% amid rising costs and digital investment.300146
Q2 2026 - Revenue up 4.3% year-over-year, but net profit down 11.6% amid higher expenses.300146
Q1 2026 - Net profit surged 19.81% despite an 8.38% revenue drop, with strong overseas growth.300146
Q4 2025 - Net profit rose 4.45% to RMB 907 million despite a 14.27% revenue decline year-over-year.300146
Q3 2025 - Revenue and net profit fell sharply in Q1 2025 amid weak sales across all major brands and channels.300146
Q1 2025 - H1 2025 revenue and profit declined sharply, with focus shifting to innovation and efficiency.300146
Q2 2025 - Revenue and profit fell over 25% and 50% year-over-year, with broad declines across brands and channels.300146
Q3 2024 - Revenue and net profit fell sharply in H1 2024, prompting strategic and operational adjustments.300146
Q2 2024 - 2024 saw a 62.6% net profit drop amid industry headwinds, with a focus on innovation for 2025.300146
Q4 2024
)
)
)
)
)
)
)
)